Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker – BTCRC

Skip to content

Home
About
Group Leaders
Research Groups
Contact

Menu

Home
About
Group Leaders
Research Groups
Contact

Search

Close

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker

May 4, 2022

https://www.mdpi.com/2073-4409/11/9/1415

Share This Post

PrevPreviousDr. Apostolos Zaravinos, leader of the ‘Cancer Genetics, Genomics & Systems Biology’ group receives the IJMS 2021 Young Investigator Award.

NextGenome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC CellsNext

More To Explore

Colon Cancer: From Epidemiology to Prevention

https://www.mdpi.com/2218-1989/12/6/499

March 2, 2023

Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer

https://www.mdpi.com/1422-0067/23/18/10933

March 2, 2023

Research Groups

Angiogenesis & Cancer Drug Discovery Group
Cancer Metastasis & Adhesion Group
Cancer Mechanobiology & Applied Biophysics Group
Microbiome & Cancer Group
Tumor Immunology & Biomarkers Group
Tumor Microenvironment, Metastasis & Experimental Therapeutics Group
Cancer Genetics, Genomics & Systems Biology Group

Angiogenesis & Cancer Drug Discovery Group
Cancer Metastasis & Adhesion Group
Cancer Mechanobiology & Applied Biophysics Group
Microbiome & Cancer Group
Tumor Immunology & Biomarkers Group
Tumor Microenvironment, Metastasis & Experimental Therapeutics Group
Cancer Genetics, Genomics & Systems Biology Group

Legal

Privacy Policy
Cookies Policy

© All rights reserved

Powered by LightBlack

Scroll to Top